22nd November 2010
Pharmaceutical consulting, according to the latest estimates from the Business Monitor International's Pharmaceuticals & Healthcare Business Environment Ratings, may be positioned to play an increasingly valuable role over the next five years. Projections...
Read >
22nd November 2010
Lean manufacturing works, not only for manufacturing processes, but also in quality control labs. Laboratories are, obviously, very different from manufacturing environments and require specific adaptations of the generic lean approach. With the proper ad...
Read >
22nd November 2010
A pharmaceutical company's lean manufacturing implementation can be either fairly seamless and efficient or met with resistance and merely partial. A lot of it has to do with perceptions and attitudes and the right implementation emphases. And these are t...
Read >
22nd November 2010
When market conditions, methods of manufacture and testing, and technology remain virtually unchanged for long periods, companies in an industry can generally manage quite well doing everything in-house. But when an industry finds itself in the throes of ...
Read >
09th November 2010
Pharmaceutical manufacturing has traditionally been batch oriented and thus fairly discontinuous in the end-to-end "process." But lean manufacturing techniques are beginning to transform the traditional for pharmaceutical companies willing to embrace and ...
Read >
08th November 2010
A relatively new development in the life sciences industry is the growing use of contract manufacturing organizations (CMOs). In response to decreasing profit margins, continuing patent expirations, and the concomitant diminishing product pipelines, compa...
Read >
08th November 2010
When it comes to process and quality control, the pharmaceutical industry has historically taken a reactive approach. When something broke, then it was fixed-that is, when a product-quality issue arose, only then was it addressed. Now, however, that's cha...
Read >
24th September 2010
Expenses surrounding R&D, production, regulatory compliance, marketing, and product distribution continue to increase. The cost of medication and various kinds of specialized health services continues to rise. In addition, the number of blockbuster drugs ...
Read >
15th September 2010
Formerly within the pharmaceutical industry, not a lot of thought was given to production and the supply chain. As long as market demand was met with quality, compliant products, production was generally ignored as an area that could lend itself to gainin...
Read >